entity

synaptic_loss

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about synaptic_loss: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections

1Hypotheses

8Analyses

1Outgoing

4Incoming

0Experiments

8Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Synaptic Loss in Alzheimer's Disease Pathway

mechanism · 2984 words

→

Outgoing (1)

Target	Relation	Type	Str
DEPRESSION	contributes_to	disease	0.56

Incoming (4)

Source	Relation	Type	Str
Alzheimer's_disease	causes	disease	0.80
phagocytosis	causes	phenotype	0.64
PHAGOCYTOSIS	causes	phenotype	0.64
tripartite_synapse_dysfunction	causes	pathological_process	0.50

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Excessive C1q/C3/CR3 complement cascade activation initiates	0.720	neurodegeneration	Synaptic pruning by microglia in neurode

Mentioning Analyses (8)

Scientific analyses that reference this entity

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

neurodegeneration | 2026-04-25 | 8 hypotheses Top: 0.640

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 7 hypotheses Top: 0.728

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

neurodegeneration | 2026-04-12 | 0 hypotheses

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety throu

neurodegeneration | 2026-04-08 | 0 hypotheses

Does SPP1-mediated synaptic engulfment represent beneficial clearance or patholo

synaptic biology | 2026-04-07 | 7 hypotheses Top: 0.708

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (8)

Multi-agent debates referencing this entity

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

active · Rounds: 4 · Score: 0.66 · 2026-04-25

The study shows SPP1 from perivascular cells drives microglial synaptic engulfme

closed · Rounds: 4 · Score: 0.70 · 2026-04-22

While SPP1 absence prevents synaptic loss, it's unclear whether this represents

closed · Rounds: 4 · Score: 0.69 · 2026-04-21

The debate revealed conflicting evidence about C1q's role - some studies show it

closed · Rounds: 4 · Score: 0.58 · 2026-04-16

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

closed · Rounds: 5 · Score: 0.95 · 2026-04-15

The study reports that complement-mediated synaptic elimination produces both co

closed · Rounds: 4 · Score: 0.83 · 2026-04-09

Synaptic pruning by microglia in early AD

closed · Rounds: 4 · Score: 0.95 · 2026-04-06

What cell types are most vulnerable in Alzheimer's Disease based on SEA-AD trans

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning synaptic_loss in their description or question text

No additional research found

synaptic_loss

Understanding Entity Pages

Wiki Pages (1)

Synaptic Loss in Alzheimer's Disease Pathway

Outgoing (1)

Incoming (4)

Targeting Hypotheses (1)

Mentioning Analyses (8)

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety throu

Does SPP1-mediated synaptic engulfment represent beneficial clearance or patholo

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Synaptic pruning by microglia in early AD

Experiments (0)

Related Papers (0)

Debates (8)

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

The study shows SPP1 from perivascular cells drives microglial synaptic engulfme

While SPP1 absence prevents synaptic loss, it's unclear whether this represents

The debate revealed conflicting evidence about C1q's role - some studies show it

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

The study reports that complement-mediated synaptic elimination produces both co

Synaptic pruning by microglia in early AD

What cell types are most vulnerable in Alzheimer's Disease based on SEA-AD trans

Related Research